Unknown

Dataset Information

0

Lysophosphatidic acid enhances vascular endothelial growth factor-C expression in human prostate cancer PC-3 cells.


ABSTRACT: Clinical evidence suggests that lymphangiogenesis and lymphatic metastasis are important processes during the progression of prostate cancer. Vascular endothelial growth factor (VEGF)-C was shown to be a key regulator in these processes. Our previous studies demonstrated that lysophosphatidic acid (LPA), a low-molecular-weight lipid growth factor, enhances VEGF-C expression in human endothelial cells. We previously demonstrated that the LPA receptor plays an important role in lymphatic development in zebrafish embryos. However, the effects of LPA on VEGF-C expression in prostate cancer are not known. Herein, we demonstrate that LPA up-regulated VEGF-C expression in three different human prostate cancer cell lines. In PC-3 human prostate cancer cells, the enhancing effects of LPA were mediated through both LPA1 and LPA3. In addition, reactive oxygen species (ROS) production and lens epithelium-derived growth factor (LEDGF) expression were involved in LPA(1/3)-dependent VEGF-C expression. Furthermore, autotaxin (ATX), an enzyme responsible for LPA synthesis, also participates in regulating VEGF-C expression. By interrupting LPA(1/3) of PC-3, conditioned medium (CM) -induced human umbilical vein endothelial cell (HUVEC) lymphatic markers expression was also blocked. In summary, we found that LPA enhances VEGF-C expression through activating LPA(1/3)-, ROS-, and LEDGF-dependent pathways. These novel findings could potentially shed light on developing new strategies for preventing lymphatic metastasis of prostate cancer.

SUBMITTER: Lin CE 

PROVIDER: S-EPMC3401111 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications

Lysophosphatidic acid enhances vascular endothelial growth factor-C expression in human prostate cancer PC-3 cells.

Lin Chuan-En CE   Chen Shee-Uan SU   Lin Chu-Cheng CC   Chang Chi-Hao CH   Lin Yueh-Chien YC   Tai Yu-Ling YL   Shen Tang-Long TL   Lee Hsinyu H  

PloS one 20120720 7


Clinical evidence suggests that lymphangiogenesis and lymphatic metastasis are important processes during the progression of prostate cancer. Vascular endothelial growth factor (VEGF)-C was shown to be a key regulator in these processes. Our previous studies demonstrated that lysophosphatidic acid (LPA), a low-molecular-weight lipid growth factor, enhances VEGF-C expression in human endothelial cells. We previously demonstrated that the LPA receptor plays an important role in lymphatic developme  ...[more]

Similar Datasets

| S-EPMC2841699 | biostudies-literature
| S-EPMC8467330 | biostudies-literature
| S-EPMC8488270 | biostudies-literature
| S-EPMC5713444 | biostudies-literature
| S-EPMC2893652 | biostudies-literature
| S-EPMC1865098 | biostudies-literature
| 2073020 | ecrin-mdr-crc
| S-EPMC3616929 | biostudies-literature
| S-EPMC3086058 | biostudies-literature
| S-EPMC10889543 | biostudies-literature